Lexology January 22, 2025
Click here to listen to the audio.
The process of transforming cutting-edge academic research into life-changing therapies is often described as moving from bench to market. Joining us today is Elizabeth Douville, President and CEO of Iricor, a cancerology and immunology research valorization center based at the University of Montreal.
Elizabeth is a leader who connects academic, industry and government ecosystems. She has a passion for scientific research and a track record of turning university innovations into biotech companies. She’s a force to be reckoned with in the life sciences.
In this episode we’ll talk about how Iricor is tackling drug development, de-risking early stage innovation and commercializing promising therapies. We’ll also talk about bridging the infamous “Valley of Death”...
Today's Sponsors
Today's Sponsor